Symptoms are not always obvious but can include pain and tenderness, swelling in the arms or legs, shortness of breath, and rapid breathing, depending on the type of VTE
Compounded Semaglutide is semaglutide prepared by a licensed compounding pharmacy under physician supervision
Study population The study population included US adults with confirmed T2D treated with SGLT2i
Comparison with other antidiabetic medicines like insulin, metformin, sulfonylureas, thiazolidinediones, -glucosidase inhibitors placebo showed no statistically significant increase in fracture risk for DPP-4i, GLP-1 RAs, or SGLT-2i
CONCLUSION The potential of these new therapies to effectively treat obesity and T2DM and radically reduce their complications pose a major challenge to the health authorities who will need to decide how these new possibilities should be implemented to the benefit of the people at risk